Related Experiment Video
Updated: Jul 10, 2026
08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Immune therapies.
Rao H Prabhala1, Nikhil C Munshi
1Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA 02115, USA.
Hematology/Oncology Clinics of North America
|November 13, 2007
Summary
Understanding immune cells and their interactions with myeloma cells is crucial for developing effective cancer immunotherapies. Further research into cell-based therapeutic approaches is needed for improved myeloma treatment.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- Immune cells play a critical role in cancer treatment and prevention.
- Significant advancements have been made in myeloma immunotherapy and immunobiology.
- Challenges remain in fully understanding the complex interplay between immune cells and myeloma tumor cells.
Purpose of the Study:
- To enhance the understanding of immune cell-tumor cell interactions in myeloma.
- To identify key obstacles in current myeloma immunotherapies.
- To advocate for the development of novel cell-based therapeutic strategies for myeloma.
Main Methods:
- Review of current literature on myeloma immunobiology and immunotherapy.
- Analysis of the interrelationships between immune cells and myeloma cells.
- Conceptualization of potential cell-based therapeutic approaches.
Main Results:
- Specific immune cell functions are vital for effective cancer treatment.
- Existing knowledge gaps hinder the complete understanding of immune cell-myeloma interactions.
- Current immunotherapies face obstacles in targeting these complex interactions.
Conclusions:
- A deeper comprehension of immune cell-tumor cell dynamics is essential for myeloma.
- Cell-based therapeutic strategies offer a promising avenue for advancing myeloma treatment.
- Further development in this area is required to overcome current therapeutic limitations.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...